Article Details

July FDA Oncology Approvals Include Options for NSCLC, Myeloma, and More

Retrieved on: 2025-08-01 14:08:03

Tags for this article:

Click the tags to see associated articles and topics

July FDA Oncology Approvals Include Options for NSCLC, Myeloma, and More. View article details on hiswai:

Excerpt

... monoclonal antibody, and an immunomodulatory agent (IMiD). 1. Related ... Laura Zitella Discusses the Growing Arsenal of Bispecific Antibodies in DLBCL.

Article found on: www.oncnursingnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo